Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The primary purpose of the study is to investigate the anti-dyskinetic effect of several doses of sarizotan in Parkinson patients in order to generate information on the dose-response relationship (dose-finding).
Epistemonikos ID: e3c8c718a2962f84eda0352990d48519b441b2e2
First added on: May 04, 2024